TradingKey

關於 IDEXX Laboratories Inc 公司

IDEXX Laboratories, Inc. 開發、生產和分銷產品，並主要爲伴侶動物獸醫、牲畜和家禽、乳製品和水檢測行業提供服務。該公司還提供人類醫療即時診斷和實驗室診斷。其部門包括伴侶動物組 (CAG)、水質產品 (水) 以及牲畜、家禽和乳製品 (LPD)。CAG 部門爲伴侶動物獸醫行業提供基於診斷和信息管理的產品和服務，包括臨牀診斷解決方案、外部參考實驗室服務以及獸醫軟件和服務。其水部門提供測試解決方案，用於準確檢測和量化水中的各種微生物參數。其 LPD 部門提供診斷測試、服務和相關儀器，用於管理牲畜和家禽的健康狀況，以提高牛奶的質量和安全性。

公司簡介

公司代碼IDXX

公司名稱IDEXX Laboratories Inc

上市日期Jun 21, 1991

CEOMr. Andrew Emerson

員工數量11000

證券類型Ordinary Share

年結日Jun 21

公司地址One Idexx Drive

城市WESTBROOK

上市交易所NASDAQ Global Select Consolidated

國家United States of America

郵編04092-2041

電話12075560300

網址https://www.idexx.com/

公司代碼IDXX

上市日期Jun 21, 1991

CEOMr. Andrew Emerson

公司高階主管

名稱

名稱/職務

職務

持股

持股變動

Mr. Michael Erickson, Ph.D.

Executive Vice President and General Manager, Point of Care Diagnostics and Telemedicine

12.58K

+18.05%

Dr. Sophie V. Vandebroek, Ph.D.

Independent Director

8.69K

+3.11%

Mr. Lawrence D. (Larry) Kingsley

Independent Chairman of the Board

8.23K

+4.39%

Mr. Michael J. Lane

Executive Vice President and General Manager, Global Reference Laboratories, Diagnostic Solutions and Information Technology

7.70K

--

Ms. Sharon E. Underberg

Executive Vice President, General Counsel, Corporate Secretary

6.12K

+3.08%

Mr. Andrew Emerson

Executive Vice President, Chief Executive Officer, Treasurer

3.84K

+60.39%

Mr. Daniel M. (Dan) Junius

Independent Director

3.00K

+9.56%

Mr. Michael Schreck

Executive Vice President and General Manager, Veterinary Software and Services, Corporate Accounts and Customer Experience

1.92K

+112.86%

Mr. Bruce L. Claflin

Independent Director

1.72K

--

Dr. Stuart M. Essig, Ph.D.

Independent Director

1.09K

+31.76%

名稱

名稱/職務

職務

持股

持股變動

Mr. Michael Erickson, Ph.D.

Executive Vice President and General Manager, Point of Care Diagnostics and Telemedicine

12.58K

+18.05%

Dr. Sophie V. Vandebroek, Ph.D.

Independent Director

8.69K

+3.11%

Mr. Lawrence D. (Larry) Kingsley

Independent Chairman of the Board

8.23K

+4.39%

Mr. Michael J. Lane

Executive Vice President and General Manager, Global Reference Laboratories, Diagnostic Solutions and Information Technology

7.70K

--

Ms. Sharon E. Underberg

Executive Vice President, General Counsel, Corporate Secretary

6.12K

+3.08%

Mr. Andrew Emerson

Executive Vice President, Chief Executive Officer, Treasurer

3.84K

+60.39%

收入明細

單位: USD更新時間: 7月6日週日

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

FY2018

業務USD

名稱

營收

佔比

CAG Diagnostics recurring revenue

806.27M

80.75%

IDEXX VetLab consumables

344.78M

34.53%

Reference laboratory diagnostic and consulting services

344.41M

34.49%

Rapid assay products

84.03M

8.42%

Veterinary software, services and diagnostic imaging systems

81.58M

8.17%

其他

-662.63M

-66.37%

地區USD

名稱

營收

佔比

United States

654.86M

65.59%

Europe & Middle East & Africa (EMEA) (Region)

204.55M

20.49%

Asia Pacific

81.73M

8.19%

Canada

37.30M

3.74%

Latin America

19.99M

2.00%

業務

地區

業務USD

名稱

營收

佔比

CAG Diagnostics recurring revenue

806.27M

80.75%

IDEXX VetLab consumables

344.78M

34.53%

Reference laboratory diagnostic and consulting services

344.41M

34.49%

Rapid assay products

84.03M

8.42%

Veterinary software, services and diagnostic imaging systems

81.58M

8.17%

其他

-662.63M

-66.37%

股東統計

更新時間: 8月19日週二

持股股東

股東類型

持股股東

佔比

The Vanguard Group, Inc.

12.30%

BlackRock Institutional Trust Company, N.A.

6.63%

State Street Global Advisors (US)

4.44%

Fundsmith LLP

3.30%

Geode Capital Management, L.L.C.

3.08%

其他

70.25%

持股股東

佔比

The Vanguard Group, Inc.

12.30%

BlackRock Institutional Trust Company, N.A.

6.63%

State Street Global Advisors (US)

4.44%

Fundsmith LLP

3.30%

Geode Capital Management, L.L.C.

3.08%

其他

70.25%

股東類型

持股股東

佔比

Investment Advisor

54.31%

Investment Advisor/Hedge Fund

32.80%

Research Firm

3.95%

Pension Fund

2.29%

Bank and Trust

2.06%

Hedge Fund

0.93%

Individual Investor

0.69%

Sovereign Wealth Fund

0.61%

Family Office

0.54%

其他

1.83%

機構持股

更新時間: 7月1日週二

報告期間

機構數

持股數

持股佔比

持股變動

2025Q2

2277

79.81M

99.73%

-1.01M

2025Q1

2279

79.02M

98.21%

-512.23K

2024Q4

2242

76.14M

93.59%

-5.30M

2024Q3

2152

77.90M

94.66%

-4.67M

2024Q2

2140

80.09M

96.98%

-924.14K

2024Q1

2154

77.56M

93.40%

-2.57M

2023Q4

2187

77.94M

93.84%

-2.83M

2023Q3

2153

79.23M

95.34%

-677.16K

2023Q2

2157

77.53M

93.40%

-1.56M

2023Q1

2158

77.14M

92.96%

-2.07M

股東持股明細

名稱

持股數

佔比

持股變動

變動比例

公告日期

The Vanguard Group, Inc.

9.82M

12.21%

+146.37K

+1.51%

Mar 31, 2025

BlackRock Institutional Trust Company, N.A.

5.44M

6.76%

+113.70K

+2.14%

Mar 31, 2025

State Street Global Advisors (US)

3.65M

4.54%

+12.32K

+0.34%

Mar 31, 2025

Fundsmith LLP

2.65M

3.29%

-14.52K

-0.55%

Mar 31, 2025

Geode Capital Management, L.L.C.

2.41M

3%

+112.62K

+4.90%

Mar 31, 2025

Baron Capital Management, Inc.

2.06M

2.56%

+54.26K

+2.71%

Mar 31, 2025

Invesco Capital Management (QQQ Trust)

1.66M

2.07%

-25.31K

-1.50%

Jun 30, 2025

Principal Global Investors (Equity)

1.13M

1.4%

+414.80K

+58.32%

Mar 31, 2025

William Blair & Company, L.L.C. (Research)

1.09M

1.36%

-14.24K

-1.29%

Mar 31, 2025

持股ETF

更新時間: 9月6日週六

機構名稱

佔比

ProShares Pet Care ETF

10.39%

First Trust Water ETF

5.65%

iShares U.S. Medical Devices ETF

5.62%

Nuveen ESG Mid-Cap Growth ETF

3.56%

Simplify Next Intangible Core Index ETF

3.22%

Hennessy Sustainable ETF

3.19%

Adaptive Core ETF

2.75%

Janus Henderson Mid Cap Growth Alpha ETF

2.63%

Invesco Raymond James SB-1 Equity ETF

2.52%

First Trust S&P 500 Economic Moat Index ETF

2.42%

ProShares Pet Care ETF

佔比10.39%

First Trust Water ETF

佔比5.65%

iShares U.S. Medical Devices ETF

佔比5.62%

Nuveen ESG Mid-Cap Growth ETF

佔比3.56%

Simplify Next Intangible Core Index ETF

佔比3.22%

Hennessy Sustainable ETF

佔比3.19%

Adaptive Core ETF

佔比2.75%

Janus Henderson Mid Cap Growth Alpha ETF

佔比2.63%

Invesco Raymond James SB-1 Equity ETF

佔比2.52%

First Trust S&P 500 Economic Moat Index ETF

佔比2.42%

分紅派息

近5年累計派現 0.00 美元

公告日期

分紅計劃

股權登記日

現金發放日

除權除息日

暫無數據

拆合股

公告日期

類型

比率

暫無數據

公告日期

類型

比率

暫無數據

IDEXX Laboratories Inc

643.990USD

IDEXX Laboratories Inc

643.990

概覽

公司

財務

分析